SOHM Inc (SHMN)

[hardlesson]

Madguppy, welcome, see below if helpful:

5 days to go! 

We're all set for our big reveal at #AACR2024 that can revolutionize colon cancer treatment.
More: https://t.co/tcmjjGEEW1$SHMN #SOHMInc #CancerResearch #ABBIE #ColonCancer pic.twitter.com/BCuV7f0wvV

— SOHM, Inc. (@sohminc) April 3, 2024

https://www.abstractsonline.com/pp8/#!/20272/presentation/1254

Witness a paradigm shift at #AARC2024 as we unveil our groundbreaking gene-editing platform! It will revolutionize colon cancer treatment.

More: https://t.co/tcmjjGEEW1 pic.twitter.com/I6gqBkOMFA

— SOHM, Inc. (@sohminc) March 25, 2024

Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy

— SOHM, Inc. (@sohminc) March 28, 2024

The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to…

— SOHM, Inc. (@sohminc) March 19, 2024

Intellectual Property Assignment to SOHM, Inc.

SOHM, Inc., a generic pharmaceutical, nutraceutical, cosmeceutical and Biotech firm, had acquired the disruptive stem cell technology and associated patents known as "ABBIE." This acquisition follows a letter of intent signed with…

— SOHM, Inc. (@sohminc) February 29, 2024

We are excited to announce that our company will participate in the American Association for Cancer Research (AACR) annual meeting in San Diego from April 5 to April 10, 2024.

At this internationally attended meeting, we will present our innovative gene-editing system, ABBIE,…

— SOHM, Inc. (@sohminc) February 1, 2024

https://www.otcmarkets.com/stock/SHMN/news


__
good weekend. hL